Compare Wockhardt with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs BIOCON - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT BIOCON WOCKHARDT/
BIOCON
 
P/E (TTM) x -22.4 17.0 - View Chart
P/BV x 1.2 2.6 45.0% View Chart
Dividend Yield % 0.0 0.4 0.7%  

Financials

 WOCKHARDT   BIOCON
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
BIOCON
Mar-18
WOCKHARDT/
BIOCON
5-Yr Chart
Click to enlarge
High Rs1,0121,188 85.2%   
Low Rs532305 174.3%   
Sales per share (Unadj.) Rs355.968.7 517.8%  
Earnings per share (Unadj.) Rs-60.37.6 -798.2%  
Cash flow per share (Unadj.) Rs-46.814.0 -334.7%  
Dividends per share (Unadj.) Rs0.011.00 1.0%  
Dividend yield (eoy) %00.1 1.0%  
Book value per share (Unadj.) Rs257.886.3 298.6%  
Shares outstanding (eoy) m110.63600.00 18.4%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x2.210.9 20.0%   
Avg P/E ratio x-12.898.9 -13.0%  
P/CF ratio (eoy) x-16.553.4 -30.9%  
Price / Book Value ratio x3.08.6 34.6%  
Dividend payout %013.2 -0.1%   
Avg Mkt Cap Rs m85,379447,900 19.1%   
No. of employees `0006.36.1 101.7%   
Total wages/salary Rs m9,3719,311 100.6%   
Avg. sales/employee Rs Th6,295.06,705.8 93.9%   
Avg. wages/employee Rs Th1,498.31,514.2 99.0%   
Avg. net profit/employee Rs Th-1,066.3736.9 -144.7%   
INCOME DATA
Net Sales Rs m39,36941,234 95.5%  
Other income Rs m1,2022,062 58.3%   
Total revenues Rs m40,57143,296 93.7%   
Gross profit Rs m188,291 0.2%  
Depreciation Rs m1,4953,851 38.8%   
Interest Rs m2,555615 415.4%   
Profit before tax Rs m-2,8305,887 -48.1%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2571,569 16.4%   
Profit after tax Rs m-6,6694,531 -147.2%  
Gross profit margin %020.1 0.2%  
Effective tax rate %-9.126.7 -34.1%   
Net profit margin %-16.911.0 -154.1%  
BALANCE SHEET DATA
Current assets Rs m33,79641,486 81.5%   
Current liabilities Rs m26,91721,413 125.7%   
Net working cap to sales %17.548.7 35.9%  
Current ratio x1.31.9 64.8%  
Inventory Days Days7964 124.0%  
Debtors Days Days8994 94.7%  
Net fixed assets Rs m39,66450,661 78.3%   
Share capital Rs m5533,000 18.4%   
"Free" reserves Rs m27,96848,808 57.3%   
Net worth Rs m28,52251,808 55.1%   
Long term debt Rs m21,73117,898 121.4%   
Total assets Rs m81,62099,897 81.7%  
Interest coverage x-0.110.6 -1.0%   
Debt to equity ratio x0.80.3 220.5%  
Sales to assets ratio x0.50.4 116.9%   
Return on assets %-5.05.2 -97.8%  
Return on equity %-23.48.7 -267.3%  
Return on capital %-7.79.6 -79.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,80712,058 81.3%   
Fx outflow Rs m1,7897,348 24.3%   
Net fx Rs m8,0194,710 170.2%   
CASH FLOW
From Operations Rs m6846,621 10.3%  
From Investments Rs m6,302-6,840 -92.1%  
From Financial Activity Rs m-7,695-2,397 321.0%  
Net Cashflow Rs m-664-2,612 25.4%  

Share Holding

Indian Promoters % 74.5 40.4 184.4%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 2.3 8.4 27.4%  
FIIs % 7.7 10.7 72.0%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 19.9 77.4%  
Shareholders   67,757 109,995 61.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   ORCHID PHARMA LTD  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  CIPLA  

Compare WOCKHARDT With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps 470 Points; Energy and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended deep in the red. The BSE Sensex fell over 550 points intraday and breached the 36,000 mark.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Sep 19, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS